Monocyte-to-HDL Ratio and Heart Attack Outcomes
Author Information
Author(s): Separham Ahmad, Aslan-abadi Naser, Sedigh Hamid, Javan-ajdadi Reza, Mehravani Kazem
Primary Institution: Cardiovascular Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Hypothesis
The study aims to assess the prognostic value of the monocyte-to-high-density lipoprotein ratio (MHR) in predicting outcomes for patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).
Conclusion
The study found that a higher monocyte-to-HDL ratio is independently associated with an increased risk of major adverse cardiovascular events and in-hospital mortality in STEMI patients undergoing PCI.
Supporting Evidence
- Higher MHR was associated with increased in-hospital mortality.
- MHR can predict major adverse cardiovascular events with reasonable sensitivity and specificity.
- Multivariate analyses indicated MHR as an independent predictor of in-hospital mortality and MACE.
Takeaway
This study shows that if you have a higher level of a certain type of blood cell compared to good cholesterol, you might be at a greater risk of serious heart problems after a heart attack.
Methodology
This was a retrospective cross-sectional study analyzing medical records of STEMI patients who underwent PCI, categorizing them based on their admission MHR.
Potential Biases
Potential biases may arise from the retrospective nature of the study and reliance on medical records.
Limitations
The study is limited by its retrospective design and the exclusion of patients with certain comorbidities.
Participant Demographics
The study included 652 patients, with 378 males (58%) and 275 females (42%), and a median age of 68 years.
Statistical Information
P-Value
0.002
Confidence Interval
1.02-1.08
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website